Improving Time to Antibiotic Administration for Pediatric Oncology Patients With New-Onset Fever
Wesley T Smith,Jay Read,Shreya Agarwal,Gengwen Tian,Shaniqua J Anum,Michelle Choe,Kristen Kurtz,Dana Tlais,Xiaofan Shen,Jill Sarro,Thomas Looney,Timothy Porea,Hannah Sauer,Julienne Brackett,M Fatih Okcu,Murali Chintagumpala,Wesley T. Smith,Shaniqua J. Anum,M. Fatih Okcu
DOI: https://doi.org/10.1200/op.23.00314
2024-02-14
JCO Oncology Practice
Abstract:PURPOSE Time to antibiotic administration (TTA) in <60 minutes for children with neutropenic fever presenting to an emergency room is associated with reduced incidence of sepsis and intensive care admission. As such, TTA is used as a national quality metric for pediatric oncology patients. At our center, in 2020, 19% of the hospitalized patients with a new fever encounter were receiving antibiotics in 90% in all pediatric patients with cancer with a new fever. METHODS A multidisciplinary team completed four Plan-Do-Study-Act cycles between March 2021 and September 2023. We implemented education initiatives, an updated handoff smartphrase guiding the on-call team, an antibiotic champion (AC) nursing role, a revised fever plan for handoff, a rapid-response team to address new fevers, and an algorithm for blood culture collection. Data were collected, analyzed, and reported biweekly with feedback sought for delays in TTA. RESULTS There was a total of 639 new fevers in 329 unique oncology patients. As of September 4, 2023, average TTA decreased from 89 minutes at baseline to 46.4 minutes for more than 12 months. The percentage of patients receiving first dose of antibiotic in <60 minutes also increased from 19% to 93.7%, which was sustained as well. The most effective interventions were creation of the AC role and streamlining the blood culture collection process. CONCLUSION This project demonstrates the importance of multidisciplinary involvement for providing optimal care. Specific implementation of targeted education, an AC role, and development of an algorithm streamlining the processes led to meaningful targeted improvements. Further analyses will explore the impact of these interventions on patient outcomes.
oncology